title: Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection.
authors.forename: Murat
authors.initials: M
authors.lastname: Salihoğlu
authors.forename: Vedat
authors.initials: V
authors.lastname: Turhan
authors.forename: Yalçin
authors.initials: Y
authors.lastname: Önem
authors.forename: Asim
authors.initials: A
authors.lastname: Ulcay
authors.forename: Günalp
authors.initials: G
authors.lastname: Uzun
authors.forename: Hakan
authors.initials: H
authors.lastname: Ay
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017576:Daptomycin / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D017719:Diabetic Foot / Q000188:drug therapy*; D003639:Hearing Loss, Sudden / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000009:adverse effects / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination
chemical_list: D000900:Anti-Bacterial Agents; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D017576:Daptomycin; D010878:Piperacillin